Medicare is introducing a new bridge program that will provide access to certain GLP-1 medications with a $50 copay starting July 1, 2026. This change aims to improve access to these drugs for eligible Medicare beneficiaries seeking treatment for weight management. Understanding how this program works can help Medicare beneficiaries prepare for the upcoming changes and make informed decisions about their healthcare.

What Are GLP-1 Medications?

GLP-1 stands for glucagon-like peptide-1. These medications help regulate blood sugar levels by stimulating insulin production and slowing digestion. They are often prescribed to people with type 2 diabetes to improve glucose control. Recently, some GLP-1 drugs have also been approved for weight management, offering new treatment options for obesity.

These drugs have shown benefits beyond blood sugar control, such as reducing cardiovascular risks and supporting weight loss.

How the Medicare GLP-1 Bridge Program Works

Starting July 1, 2026, Medicare will cover GLP-1 medications with a fixed copay of $50 for eligible beneficiaries. This means that instead of paying the full price or a percentage of the cost, beneficiaries will pay a flat $50 per prescription fill.

Key points about the benefit:

• Applies to certain GLP-1 medications approved for weight management and included in the Medicare GLP-1 Bridge Program

• Requires a prescription from a healthcare provider

• Available to eligible beneficiaries enrolled in a Medicare Part D prescription drug plan

• Eligibility and prior authorization requirements may apply.

• The Bridge Program is available from July 1, 2026 through December 31, 2027

  
  

This new coverage aims to reduce out-of-pocket costs, making these effective medications more affordable for seniors and others on Medicare.

Which GLP-1 Medications are covered?

• Wegovy® - both the injectable and tablet formulations

• Zepbound®: Only the KwikPen® formulation.

• Foundayo®: All formulations

Who Qualifies for the Benefit?

Medicare beneficiaries who are enrolled in a Medicare Part D plan and meet the Medicare GLP-1 Bridge Program eligibility requirements may qualify for this benefit.. It is important to check with your specific Part D plan to confirm coverage details and any additional requirements.

People who are prescribed eligible GLP-1 medications for weight management may benefit the most from this program. If you currently use these medications or your doctor recommends them, this new benefit can lower your medication expenses significantly.

What to Do Before July 2026

To prepare for the new Medicare GLP-1 bridge program, consider these steps:

• Review your current Medicare Part D plan to understand your drug coverage

• Talk to your healthcare provider about GLP-1 medications and whether they are right for you

• Keep track of your medication costs now to compare savings after the benefit starts

• Stay informed about any updates from Medicare or your plan provider regarding this benefit

  
  

Planning ahead can help you take full advantage of the $50 copay and manage your health expenses better.

Final Thoughts on the Medicare GLP-1 Benefit

The introduction of the $50 GLP-1 medication bridge program under Medicare starting July 2026 offers a promising opportunity for many eligible beneficiaries to access certain weight-management treatments at a lower cost. By understanding how this program works and preparing in advance, you can make smarter healthcare choices and potentially improve your health outcomes.

If you or a loved one uses GLP-1 drugs, keep an eye on Medicare announcements and consult your healthcare provider to make the most of this upcoming change. Staying informed and proactive will help you navigate the new benefit smoothly and affordably.

If you would like additional information or need help determining if you are eligible, please give us a call at (804) 898-3404. We are here to help.

SOURCES

• GLP-1 Key Facts - https://nam.edu

• Medicare GLP-1 Bridge - https://cms.gov

• GLP-1 Weight-Loss Drug Demonstration begins July 1, 2026 - medicarerights.org